Incidence of Ischaemic Heart Disease in Men and Women With End-Stage Kidney Disease: A Cohort Study

被引:5
|
作者
O'Lone, Emma [1 ,2 ]
Kelly, Patrick J. [1 ]
Masson, Philip [1 ,2 ]
Kotwal, Sradha [3 ,4 ]
Gallagher, Martin [5 ,6 ]
Cass, Alan [7 ]
Craig, Jonathan C. [8 ]
Webster, Angela C. [1 ,9 ]
机构
[1] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia
[2] Childrens Hosp Westmead, Ctr Kidney Res, Sydney, NSW, Australia
[3] Univ Sydney, George Inst Global Hlth, Sydney, NSW, Australia
[4] Prince Wales Hosp, Sydney, NSW, Australia
[5] Univ New South Wales, George Inst Global Hlth, Sydney, NSW, Australia
[6] Univ Sydney, Concord Clin Sch, Sydney, NSW, Australia
[7] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT, Australia
[8] Hinders Univ, Coll Med & Publ Hlth, Adelaide, SA, Australia
[9] Westmead Hosp, Ctr Renal & Transplant Res, Sydney, NSW, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
Cardiac disease; Epidemiology; End-stage kidney disease; ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; CORONARY-HEART; RENAL-DISEASE; PRIMARY-PREVENTION; RANDOMIZED-TRIALS; SEX-DIFFERENCES; EVENT RATES; TRENDS; RISK;
D O I
10.1016/j.hlc.2020.03.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The incidence of ischaemic heart disease (IHD) has fallen consistently in the general population; attributed to effective primary prevention strategies. Differences in incidence have been demonstrated by sex. Whether this fall in incidence and sex differences is mirrored in people with end-stage kidney disease (ESKD) is unclear. We aimed to establish the relative risk of H-ID events in the ESKD population. Methods We performed a retrospective cohort study from 2000 to 2010 in people with ESKD in New South Wales. We performed data linkage of the Australia and New Zealand Dialysis and Transplant Registry and state wide hospital admission and death registry data and compared this to general population data. The primary outcome was the incidence rate, incidence rate ratio (IRR), and time-trend for any IHD event. We calculated these using indirect standardisation by IHD event. Results 10,766 participants, contributed 44,149 years of observation time. Incidence rates were substantially higher than the general population for all IHD events (any IHD event: IRR 1.8, 95% confidence interval [CI] 1.7-1.9 for men, IRR 3.4, 95% CI 3.1-3.6 for women). Excess risk was higher in younger people (age 30-49 IRR 4.8, 95% CI 4.2-5.4), and in women with a three-fold increase risk overall and nearly a 10-fold increase in risk in young women (female age 30-49 years: IRR 9.8 95% CI 7.7-12.3), results were similar for angina and acute myocardial infarction. Ischaemic heart disease rates showed some decline for men over time, (ratio of IRR 0.93, 95% CI 0.90-0.95) but were stable for women (ratio of IRR 0.97, 95% CI 0.94-1.01). Conclusions People with ESKD have substantially higher rates of IHD than the general population, especially women, in whom no improvement appears evident over the past 10 years.
引用
收藏
页码:1517 / 1526
页数:10
相关论文
共 50 条
  • [1] End-stage kidney disease in Fiji
    Krishnan, Amrish
    Chandra, Yogeshni
    Malani, Joji
    Jesudason, Shilpanjali
    Sen, Shaundeep
    Ritchie, Angus G.
    INTERNAL MEDICINE JOURNAL, 2019, 49 (04) : 461 - 466
  • [2] End-stage kidney disease in patients with clinically manifest vascular disease; incidence and risk factors: results from the UCC-SMART cohort study
    Ostergaard, Helena Bleken
    Westerink, Jan
    Verhaar, Marianne C.
    Bots, Michiel L.
    Asselbergs, Folkert W.
    de Borst, Gert J.
    Kappelle, L. Jaap
    Visseren, Frank L. J.
    van der Leeuw, Joep
    JOURNAL OF NEPHROLOGY, 2021, 34 (05) : 1511 - 1520
  • [3] Estradiol and mortality in women with end-stage kidney disease
    Ramesh, Sharanya
    James, Matthew T.
    Holroyd-Leduc, Jayna M.
    Wilton, Stephen B.
    Seely, Ellen W.
    Hemmelgarn, Brenda R.
    Tonelli, Marcello
    Wheeler, David C.
    Ahmed, Sofia B.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 (11) : 1965 - 1972
  • [4] Progression to end-stage kidney disease in Japanese children with chronic kidney disease: results of a nationwide prospective cohort study
    Ishikura, Kenji
    Uemura, Osamu
    Hamasaki, Yuko
    Ito, Shuichi
    Wada, Naohiro
    Hattori, Motoshi
    Ohashi, Yasuo
    Tanaka, Ryojiro
    Nakanishi, Koichi
    Kaneko, Tetsuji
    Honda, Masataka
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (04) : 878 - 884
  • [5] Quality of Care in Chronic Kidney Disease and Incidence of End-stage Renal Disease in Older Patients A Cohort Study
    Fukuma, Shingo
    Ikenoue, Tatsuyoshi
    Shimizu, Sayaka
    Norton, Edward C.
    Saran, Rajiv
    Yanagita, Motoko
    Kato, Genta
    Nakayama, Takeo
    Fukuhara, Shunichi
    Funakoshi, T.
    Goto, Y.
    Goto, E.
    Hanaki, N.
    Hiragi, S.
    Iwao, T.
    Kawakami, K.
    Kondo, N.
    Kunisawa, S.
    Mori, Y.
    Nakatsui, M.
    Neff, Y.
    Ohtera, S.
    Okamoto, K.
    Otsubo, T.
    Saito, H.
    Saito, Y.
    Sakai, M.
    Sato, I
    Seto, K.
    Takahashi, Y.
    Yamashita, K.
    Yoshida, S.
    MEDICAL CARE, 2020, 58 (07) : 625 - 631
  • [6] Risk Factors for Stroke in People with End-Stage Kidney Disease: A Cohort Study
    Masson, Philip
    Kotwal, Sradha
    Kelly, Patrick J.
    Craig, Jonathan C.
    Lindley, Richard I.
    Gallagher, Martin
    Cass, Alan
    Webster, Angela C.
    CEREBROVASCULAR DISEASES, 2016, 42 (5-6) : 428 - 438
  • [7] Ischemic Heart Disease in Patients with End-Stage Kidney Disease
    Tanaka, Yuri
    Joki, Nobuhiko
    Hase, Hiroki
    BLOOD PURIFICATION, 2015, 40 (04) : 332 - 336
  • [8] Lupus Nephritis and End-stage Kidney Disease
    Maroz, Natallia
    Segal, Mark S.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2013, 346 (04) : 319 - 323
  • [9] Associations of kidney tests at medical facilities and health checkups with incidence of end-stage kidney disease: a retrospective cohort study
    Yoshimura, Ryuichi
    Yamamoto, Ryohei
    Shinzawa, Maki
    Kataoka, Rie
    Ahn, Mina
    Ikeguchi, Nami
    Wakida, Natsuki
    Toki, Hiroshi
    Moriyama, Toshiki
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [10] Incidence and survival of end-stage kidney disease due to polycystic kidney disease in Australia and New Zealand (1963-2014)
    Fernando, Mangalee R.
    Dent, Hannah
    McDonald, Stephen P.
    Rangan, Gopala K.
    POPULATION HEALTH METRICS, 2017, 15